Papillomavirus E6 PDZ interactions can be replaced by repression of p53 to promote episomal human papillomavirus genome maintenance

Journal of Virology

Volumn 88, Issue 5, 2014, Pages 3027-3030

  Brimer, Nicole ^a   Vande Pol, Scott B ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAPILLOMAVIRUS E6 PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYMATIC DEGRADATION; ENZYME REPRESSION; GENE DELETION; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN TARGETING; VIRUS GENOME; VIRUS NEUTRALIZATION; VIRUS REPLICATION; WART VIRUS;

CELL LINE; DNA REPLICATION; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PDZ DOMAINS; PROTEIN BINDING; REPRESSOR PROTEINS; RNA INTERFERENCE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84896736685     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02360-13     Document Type: Article

References (37)

1. zur Hausen H. 2009. Papillomaviruses in the causation of human cancers-a brief historical account. Virology 384:260-265. http://dx.doi.org/10.1016/j .virol.2008.11.046.
2. Roman A, Munger K. 2013. The papillomavirus E7 proteins. Virology 445:138-168. http://dx.doi.org/10.1016/j.virol.2013.04.013.
3. Vande Pol SB, Klingelhutz AJ. 2013. Papillomavirus E6 oncoproteins. Virology 445:115-137. http://dx.doi.org/10.1016/j.virol.2013.04.026.
4. Demers GW, Halbert CL, Galloway DA. 1994. Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Virology 198:169-174. http://dx.doi.org /10.1006/viro.1994.1019.
5. Jones DL, Thompson DA, Munger K. 1997. Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Virology 239:97-107. http://dx.doi.org/10.1006 /viro.1997.8851.
6. Zhou X, Munger K. 2009. Expression of the human papillomavirus type 16 E7 oncoprotein induces an autophagy-related process and sensitizes normal human keratinocytes to cell death in response to growth factor deprivation. Virology 385:192-197. http://dx.doi.org/10.1016/j.virol.2008.12.003.
7. Eichten A, Westfall M, Pietenpol JA, Munger K. 2002. Stabilization and functional impairment of the tumor suppressor p53 by the human papillomavirus type 16 E7 oncoprotein. Virology 295:74-85. http://dx.doi.org /10.1006/viro.2002.1375.
8. Huibregtse JM, Scheffner M, Howley PM. 1993. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell. Biol. 13: 4918-4927.
9. Brimer N, Lyons C, Vande Pol SB. 2007. Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein. Virology 358:303-310. http://dx.doi.org/10.1016/j.virol.2006.08.038.
10. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495-505. http://dx.doi.org/10.1016 /0092-8674(93)90384-3.
11. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136. http://dx.doi.org/10 .1016/0092-8674(90)90409-8.
12. Kiyono T, Hiraiwa A, Fujita M, Hayashi Y, Akiyama T, Ishibashi M. 1997. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. U. S. A. 94:11612-11616. http://dx.doi.org/10 .1073/pnas.94.21.11612.
13. Nakagawa S, Huibregtse JM. 2000. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol. Cell. Biol. 20:8244-8253. http://dx.doi.org/10.1128/MCB.20.21.8244-8253.2000.
14. Jing M, Bohl J, Brimer N, Kinter M, Vande Pol SB. 2007. Degradation of tyrosine phosphatase PTPN3 (PTPH1) by association with oncogenic human papillomavirus E6 proteins. J. Virol. 81:2231-2239. http://dx.doi .org/10.1128/JVI.01979-06.
15. Spanos WC, Hoover A, Harris GF, Wu S, Strand GL, Anderson ME, Klingelhutz AJ, Hendriks W, Bossler AD, Lee JH. 2008. The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth. J. Virol. 82:2493-2500. http://dx.doi.org/10.1128/JVI .02188-07.
16. Glaunsinger BA, Lee SS, Thomas M, Banks L, Javier R. 2000. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and highrisk papillomavirus E6 oncoproteins. Oncogene 19:5270-5280. http://dx .doi.org/10.1038/sj.onc.1203906.
17. Lee SS, Glaunsinger B, Mantovani F, Banks L, Javier RT. 2000. Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J. Virol. 74:9680-9693. http://dx.doi.org/10.1128/JVI.74.20.9680-9693.2000.
18. Thomas M, Laura R, Hepner K, Guccione E, Sawyers C, Lasky L, Banks L. 2002. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 21:5088-5096. http: //dx.doi.org/10.1038/sj.onc.1205668.
19. Latorre IJ, Roh MH, Frese KK, Weiss RS, Margolis B, Javier RT. 2005. Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells. J. Cell Sci. 118:4283-4293. http://dx.doi.org/10.1242/jcs.02560.
20. Jeong KW, Kim HZ, Kim S, Kim YS, Choe J. 2007. Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation. Oncogene 26:487-499.
21. Boon SS, Banks L. 2013. High-risk human papillomavirus E6 oncoproteins interact with 14-3-3zeta in a PDZ binding motif-dependent manner. J. Virol. 87:1586-1595. http://dx.doi.org/10.1128/JVI.02074-12.
22. Nguyen ML, Nguyen MM, Lee D, Griep AE, Lambert PF. 2003. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J. Virol. 77: 6957-6964. http://dx.doi.org/10.1128/JVI.77.12.6957-6964.2003.
23. Nguyen MM, Nguyen ML, Caruana G, Bernstein A, Lambert PF, Griep AE. 2003. Requirement of PDZ-containing proteins for cell cycle regula-tion and differentiation in the mouse lens epithelium. Mol. Cell. Biol. 23:8970-8981. http://dx.doi.org/10.1128/MCB.23.24.8970-8981.2003.
24. Watson RA, Thomas M, Banks L, Roberts S. 2003. Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes. J. Cell Sci. 116:4925-4934. http://dx.doi.org/10.1242/jcs.00809.
25. Lee C, Laimins LA. 2004. Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis ofhumanpapillomavirus type 31. J. Virol. 78:12366-12377. http://dx.doi.org/10.1128/JVI.78.22.12366-12377.2004.
26. Thomas JT, Hubert WG, Ruesch MN, Laimins LA. 1999. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc. Natl. Acad. Sci. U. S. A. 96:8449-8454. http://dx.doi.org/10 .1073/pnas.96.15.8449.
27. Park RB, Androphy EJ. 2002. Genetic analysis of high-risk E6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. J. Virol. 76:11359-11364. http://dx.doi.org/10.1128/JVI.76.22 .11359-11364.2002.
28. Allen-Hoffmann BL, Schlosser SJ, Ivarie CA, Sattler CA, Meisner LF, O'Connor SL. 2000. Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J. Investig. Dermatol. 114:444-455. http://dx.doi.org/10.1046/j.1523-1747 .2000.00869.x.
29. Genther SM, Sterling S, Duensing S, Munger K, Sattler C, Lambert PF. 2003. Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle. J. Virol. 77:2832-2842. http://dx.doi.org/10.1128/JVI.77.5.2832-2842.2003.
30. Collins AS, Nakahara T, Do A, Lambert PF. 2005. Interactions with pocket proteins contribute to the role of human papillomavirus type 16 E7 in the papillomavirus life cycle. J. Virol. 79:14769-14780. http://dx.doi .org/10.1128/JVI.79.23.14769-14780.2005.
31. Nicolaides L, Davy C, Raj K, Kranjec C, Banks L, Doorbar J. 2011. Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance. Virology 414:137-145. http://dx.doi.org /10.1016/j.virol.2011.03.017.
32. Butz K, Shahabeddin L, Geisen C, Spitkovsky D, Ullmann A, Hoppe-Seyler F. 1995. Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene 10:927-936.
33. Tervahauta AI, Syrjanen SM, Vayrynen M, Saastamoinen J, Syrjanen KJ. 1993. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions. Anticancer Res. 13:1107-1111.
34. Kimple RJ, Smith MA, Blitzer GC, Torres AD, Martin JA, Yang RZ, Peet CR, Lorenz LD, Nickel KP, Klingelhutz AJ, Lambert PF, Harari PM. 2013. Enhanced radiation sensitivity in HPV-positive head and neck cancer. Cancer Res. 73:4791-4800. http://dx.doi.org/10.1158/0008-5472 .CAN-13-0587.
35. Ossovskaya VS, Mazo IA, Chernov MV, Chernova OB, Strezoska Z, Kondratov R, Stark GR, Chumakov PM, Gudkov AV. 1996. Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. Proc. Natl. Acad. Sci. U. S. A. 93:10309-10314. http://dx.doi .org/10.1073/pnas.93.19.10309.
36. Cooper B, Brimer N, Vande Pol SB. 2007. Human papillomavirus E6 regulates the cytoskeleton dynamics of keratinocytes through targeted degradation of p53. J. Virol. 81:12675-12679. http://dx.doi.org/10.1128 /JVI.01083-07.
37. Delury CP, Marsh EK, James CD, Boon SS, Banks L, Knight GL, Roberts S. 2013. The role of protein kinase A regulation of the E6 PDZbinding domain during the differentiation-dependent life cycle of human papillomavirus type 18. J. Virol. 87:9463-9472. http://dx.doi.org/10.1128 /JVI.01234-13.